This content is machine translated IBDmatters - Advanced Therapeutic Treatments Examinations and considerations before therapy Crohn’s disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the gastrointestinal tract (inflammatory bowel disease, IBD). Aspects that should be considered in particular before starting treatment, but...… CME-Test
View Post 11 min This content is machine translated IBD matters - clinical studies Differences in design and their significance for interpretation What study phases does a new active substance go through before it reaches clinical practice? What differences are there in the designs of clinical trials?Which aspects are important for interpreting… CME-Test
View Post 11 min This content is machine translated IBD matters - clinical studies Differences in design and their significance for interpretation What study phases does a new active substance go through before it reaches clinical practice? What differences are there in the designs of clinical trials? Which aspects are important for… CME-Test
View Post 3 min This content is machine translated IBD and exposure to altitude Don’t fly so high, sick patient Inflammatory bowel disease (IBD) can have many causes. However, the connection with exposure to altitude has not yet been investigated prospectively. Scientists from Zurich have now approached this question with…
View Post 11 min This content is machine translated IBD matters: Module four Molecular mechanisms in pathogenesis and treatment. Studies have shown that altered immune cell transport and pathogenic immune cells are critical factors responsible for mucosal inflammation and tissue destruction in IBD. A defective intestinal barrier and microbial… CME-Test
View Post 13 min This content is machine translated Chronic inflammatory bowel disease Treatment options for vulnerable patient populations Vulnerable patient populations with inflammatory bowel disease (IBD) require individualized and advanced treatment options. For example, the proportion of childless individuals with IBD is increased, often due to inadequate information… CME-Test
View Post 8 min This content is machine translated Chronic inflammatory bowel disease Innovative therapeutic approaches for IBD Last year, the integrin inhibitor or leukocyte migration inhibitor vedolizumab was approved in Switzerland for Crohn’s disease and ulcerative colitis. In addition, biosimilars for infliximab have entered the market. Furthermore,…
